Кератопротекторная терапия у пациентов после эксимерлазерной коррекции зрения

Abstract

Observational study of patients after excimerlaser vision correction by LASEK method. Purpose: to estimate efficacy HILOZAR-COMOD® solution in patients after excimerlaser vision correction. Patients and methods: We examined 80 eyes (40 patients) after excimer laser correction by LASIK method. All patients were divided in 2 groups. The patients from the first group were treated with by standard drug’s scheme, included deprotein izing the dialysate from the blood of healthy dairy calves (Solkoseryl® eye gel). HILOZAR-COMOD ® was prescribed as cornea protector in the 2 group of patients. Results: In the first group complete cornea epitalization by biomicroscopy in 70 % eyes after 48 hours of excimerlaser vision correction was found. Minimal unepitalization areas were diagnosed in 30 % (12 eyes). In the second group complete cornea epitalization was found in 82,5 % eyes (33 eyes) in the same term after excimerlaser correction. Cornea epitelium defects in optical area were diagnosed in the17,5 % eyes. The difference between number of patients with cornea epitelium defects first and second groups was 12,5 %. 97,5 % patients (39 eyes) of second group (HILOZAR-COMOD ®) had complete cornea epitelization after 72 hours of excimer laser correction. In the same term unepitelization areas were found in 3 eyes (7,5 %) in patients of first group. It was to 5 % more than in the first group, where dexpantenol and hyaluronic acid was used (complete cornea epitalization in first group was found in 37 eyes). Conclusions: The combined medicine included dexpantenol and hyaluronic acid decreases intensity of the dry eye symptoms, stimulate quick and full cornea healing and decrease the risk of postoperative complications risk.